Advanced search    

Search: authors:"Mingxia Wu"

4 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Distribution of Microbes and Drug Susceptibility in Patients with Diabetic Foot Infections in Southwest China

Received 5 February 2018; Accepted 11 June 2018; Published 5 August 2018 Academic Editor: João R. de Sá Copyright © 2018 Mingxia Wu et al. This is an open access article distributed under the Creative ... conflicts of interest. Authors’ Contributions Mingxia Wu and Hang Pan contributed to this work. Acknowledgments This research was supported by the grant of the National Natural Science Foundation of China

SPE-UHPLC-FLD Method for the Simultaneous Determination of Five Anthraquinones in Human Urine Using Mixed-Mode Bis(tetraoxacalix[2]arene[2]triazine) Modified Silica as Sorbent

Zhifen Deng,2 Mingxia Wu,1 and Wei Liu1 1Henan University of Chinese Medicine, Zhengzhou 450008, China 2College of Chemistry and Molecular Engineering, Zhengzhou University, Zhengzhou 450052, China

SPE-UHPLC-FLD Method for the Simultaneous Determination of Five Anthraquinones in Human Urine Using Mixed-Mode Bis(tetraoxacalix[2]arene[2]triazine) Modified Silica as Sorbent

Zhifen Deng,2 Mingxia Wu,1 and Wei Liu1 1Henan University of Chinese Medicine, Zhengzhou 450008, China 2College of Chemistry and Molecular Engineering, Zhengzhou University, Zhengzhou 450052, China

The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE−/− Mice

Background. Our study aimed to observe the effect of sodium glucose cotransporter-2 (SGLT2) inhibitor dapagliflozin on diabetic atherosclerosis and investigate the subsequent mechanism. Methods. Aortic atherosclerosis was induced in streptozotocin induced diabetic ApoE−/− mice by feeding with high-fat diet, and dapagliflozin was administrated intragastrically for 12 weeks as...